Starton Therapeutics, Inc.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Starton Therapeutics, Inc..The latest application filed is for "stable solutions of immunomodulatory imide compounds for parenteral use".
- Starton Therapeutics, Inc. - Paramus NJ US
- Starton Therapeutics, Inc. - New York NY US
| Patent | Date |
|---|---|
| Stable Solutions of Immunomodulatory Imide Compounds for Parenteral Use App 20220218687 - Hartwig; Rod L. ; et al. | 2022-07-14 |
| Continuous Delivery of Lenalidomide and Other Immunomodulatory Agents App 20220054473 - Borovinskaya; Marina ; et al. | 2022-02-24 |
| Use Of Olanzapine For Treatment Of Parp-inhibitor-induced Nausea App 20220040194 - Waisman; Pedro Lichtinger ; et al. | 2022-02-10 |
| Continuous delivery of lenalidomide and other immunomodulatory agents Grant 11,197,852 - Borovinskaya , et al. December 14, 2 | 2021-12-14 |
| Treatment Of Vomiting And Nausea With Minimum Dose Of Olanzapine App 20210244679 - Oliver; James ; et al. | 2021-08-12 |
| Transdermal Delivery Of Dronabinol App 20210236417 - Plakogiannis; Fotios M. ; et al. | 2021-08-05 |
| Transdermal Delivery Of Dronabinol App 20210220325 - Plakogiannis; Fotios M. ; et al. | 2021-07-22 |
| Transdermal Delivery Of Dronabinol App 20210100737 - Plakogiannis; Fotios M. ; et al. | 2021-04-08 |
| Continuous Delivery Of Lenalidomide And Other Immunomodulatory Agents App 20200330445 - BOROVINSKAYA; Marina ; et al. | 2020-10-22 |
| CAGE Code | 8CHS9 | STARTON THERAPEUTICS, INC. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 